The global biological safety testing products and services market size
is expected to reach a value of USD 6.9 billion by 2026, according to a new
report by Grand View Research, Inc., exhibiting a CAGR of 12.3% The market is
predominantly driven by increasing production of biologics, which is boosting
the need for highly efficient biological safety testing tools. Rising disease
burden is expected to be a major factor responsible for high production of
biologics, thereby contributing to market growth.
Increasing prevalence of lifestyle-associated
chronic diseases such as cancer and diabetes is a key factor contributing to
rise in drug development and subsequent commercialization. This is expected to
increase the need for scrutinizing & ensuring safety of targeted and
specialized therapies, evaluating outcomes, and circumventing probable
shortcomings. In addition, pharmaceutical and biotechnology companies are
increasingly incorporating biological safety testing products and services to
produce highly potent and contamination-free biologics to cater to the large
number of people suffering from target diseases. Viral safety testing is
proving to be one of the primary concerns of most companies as it is a critical
component of chemistry, manufacturing, and control of biologics. This is
creating growth opportunities in the market.
Laboratory-based contamination is leading to
development and refinement of workstations through incorporation of biological
safety products and services. Increasing need to work with tissue cultures,
maintain sterility of cell lines, and minimize cross-contamination has
increased concerns regarding product integrity. Rising intervention by
government healthcare organizations to implement good manufacturing practices
and subsequent testing & control at every production stage is expected to
widen the scope for growth.
Browse full research report on Biological
Safety Testing Products & Services Market:
https://www.grandviewresearch.com/industry-analysis/biological-safety-testing-market
Further key
findings from the study suggest:
- On the basis of product, reagents and kits
accounted for the largest share in 2018 as they are major components that
are extensively used in research and clinical laboratories
- The instruments segment, on the other hand, is
expected to grow at a lucrative CAGR during the forecast period due to
rising demand from various clinical and research laboratories
- On the basis of application, vaccines &
therapeutics segment is expected to grow at a significant CAGR during the
forecast period mainly owing to increase in disease outbreaks over the
years
- Bioburden tests are expected to grow at a
lucrative rate during the forecast period owing to their high adoption to
determine bioburden limit in a wide range of biologics and medical devices
- North America dominated the global biological
safety testing products and services market in 2018 owing to high R&D
investments in biotechnology and huge chronic disease burden
- Asia Pacific is expected to grow at an
exponential CAGR during the forecast period owing to increase in healthcare
spending
- Some of the key players are Charles River
Laboratories International, Inc.; Lonza Group AG; MilliporeSigma; SGS SA;
Sartorius Stedim BioOutsource Limited; and BSL Bioservice Scientific
Laboratories GmbH.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/biological-safety-testing-market/request/rs1
Grand
View Research has segmented biological safety testing products & services
market on the basis of product, application, test type, and region:
Biological
Safety Testing Product & Services Product Outlook (Revenue, USD
Million, 2015 - 2026)
- Reagents & Kits
- Instruments
- Services
Biological
Safety Testing Product & ServicesApplication Outlook (Revenue, USD
Million, 2015 - 2026)
- Vaccines &
Therapeutics
- Blood &
Blood-based Products
- Gene Therapy
- Tissue &
Tissue-based Products
- Stem Cell
Biological
Safety Testing Product & ServicesTest Type Outlook (Revenue, USD
Million, 2015 - 2026)
- Endotoxin Tests
- Sterility Tests
- Cell Line
Authentication & Characterization Tests
- Bioburden Tests
- Adventitious Agent
Detection Tests
- Residual Host
Contamination Detection Tests
- Others
Biological
Safety Testing Product & Services Regional Outlook (Revenue, USD
Million, 2015 - 2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment